FGLGX
Price
$23.90
Change
+$0.21 (+0.89%)
Updated
May 13 closing price
Net Assets
19.59B
VFINX
Price
$543.78
Change
+$3.92 (+0.73%)
Updated
May 13 closing price
Net Assets
1.33T
Ad is loading...

FGLGX vs VFINX

Header iconFGLGX vs VFINX Comparison
Open Charts FGLGX vs VFINXBanner chart's image
Fidelity Series Large Cap Stock
Price$23.90
Change+$0.21 (+0.89%)
VolumeN/A
Net Assets19.59B
Vanguard 500 Index Investor
Price$543.78
Change+$3.92 (+0.73%)
VolumeN/A
Net Assets1.33T
FGLGX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FGLGX vs. VFINX commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGLGX is a Buy and VFINX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.34T vs. FGLGX (19.6B). FGLGX pays higher dividends than VFINX: FGLGX (1.52) vs VFINX (1.25). FGLGX was incepted earlier than VFINX: FGLGX (12 years) vs VFINX (49 years). VFINX (0.14) is less costly to investors than FGLGX (0.00). FGLGX is a more actively managed with annual turnover of: 18.00 vs. VFINX (2.00). FGLGX (0) and VFINX (0) have matching initial minimum investment requirements. VFINX annual gain was more profitable for investors over the last year : 11.96 vs. FGLGX (8.44). FGLGX (107.19) and VFINX (104.79) have equivalent 5 years return.
FGLGXVFINXFGLGX / VFINX
Total Expense Ratio0.000.14-
Annual Report Gross Expense Ratio0.000.14-
Fund Existence12 years49 years-
Gain YTD3.224-0.536-601%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets19.6B1.34T1%
Annual Yield % from dividends1.521.25121%
Returns for 1 year8.4411.9671%
Returns for 3 years44.1145.2697%
Returns for 5 years107.19104.79102%
Returns for 10 years93.96175.4954%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRCC6.15-0.04
-0.65%
Monroe Capital Corp
DGX174.49-1.41
-0.80%
Quest Diagnostics
ACAD17.20-0.32
-1.83%
ACADIA Pharmaceuticals
CARM0.19-0.01
-3.73%
Carisma Therapeutics
RCKT6.61-0.38
-5.50%
Rocket Pharmaceuticals